Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

Dementia l: Introduction

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Educational attainment and cognitive behavioral therapy treatment outcome in late-life depression: A secondary analysis of a randomized controlled trial.

Journal of affective disorders·2025

Same author

Progress in the Treatment of Alzheimer's Disease Is Needed - Position Statement of European Alzheimer's Disease Consortium (EADC) Investigators.

The journal of prevention of Alzheimer's disease·2024

Same author

Editorial: Lecanemab: Appropriate Use Recommendations - A Commentary from a European Perspective.

The journal of prevention of Alzheimer's disease·2023

Same author

Search for Wives.

Hall's journal of health·2022

Same author

Exploring barriers and solutions in advancing cross-centre population data science.

International journal of population data science·2021

Same author

Surprising impact of stromal TIL's on immunotherapy efficacy in a real-world lung cancer study.

Lung cancer (Amsterdam, Netherlands)·2021

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Transcranial Pulse Stimulation for Alzheimer's Patients

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

Turning principles into practice in Alzheimer's disease.

J Lindesay¹, R Bullock, H Daniels

¹University of Leicester, Leicester, UK. jebl1@leicester.ac.uk

International Journal of Clinical Practice

|June 10, 2010

Summary

Dementia prevalence is rising globally, impacting patients and caregivers. This review addresses challenges in dementia diagnosis and care, aligning with the Alzheimer's Disease International Charter principles for better management.

More Related Videos

Placement of Extracranial Stimulating Electrodes and Measurement of Cerebral Blood Flow and Intracranial Electrical Fields in Anesthetized Mice

Placement of Extracranial Stimulating Electrodes and Measurement of Cerebral Blood Flow and Intracranial Electrical Fields in Anesthetized Mice

Published on: June 2, 2023

Related Experiment Videos

Last Updated: Jun 12, 2026

Transcranial Pulse Stimulation for Alzheimer's Patients

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

Placement of Extracranial Stimulating Electrodes and Measurement of Cerebral Blood Flow and Intracranial Electrical Fields in Anesthetized Mice

Placement of Extracranial Stimulating Electrodes and Measurement of Cerebral Blood Flow and Intracranial Electrical Fields in Anesthetized Mice

Published on: June 2, 2023

Area of Science:

Neurology
Public Health
Gerontology

Background:

Global dementia prevalence is increasing, posing significant challenges to individuals, families, and caregivers.
Existing issues hinder effective management and control of dementia conditions.
The Alzheimer's Disease International (ADI) Global Alzheimer's Disease Charter (2008) outlines six key principles for a proactive approach.

Purpose of the Study:

To review critical aspects and challenges in dementia diagnosis and treatment.
To evaluate current practices against the six principles of the ADI Charter.
To emphasize the need for improved dementia care strategies.

Main Methods:

Literature review and analysis of current dementia diagnosis and treatment strategies.
Discussion of challenges in dementia care in the context of the ADI Charter principles.
Synthesis of information to highlight areas for improvement in dementia management.

Main Results:

Significant challenges persist in dementia diagnosis, treatment, and overall care.
Alignment with ADI Charter principles is crucial for advancing dementia care.
Key areas for focus include awareness, human rights, caregiver support, healthcare access, optimal diagnosis/treatment, and public health interventions.

Conclusions:

While a cure for Alzheimer's disease remains elusive, immediate improvements in patient care are achievable.
Healthcare professionals must collaborate to manage dementia effectively using available tools.
Implementing the ADI Charter principles is essential for enhancing the lives of those affected by dementia.